Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
280,617,967
-
Share change
-
-984,688
-
Total reported value
-
$336,678,756
-
Put/Call ratio
-
0%
-
Price per share
-
$1.20
-
Number of holders
-
160
-
Value change
-
-$1,077,649
-
Number of buys
-
76
-
Number of sells
-
57
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2025
As of 30 Jun 2025,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
280,617,967 shares.
The largest 10 holders included
Casdin Capital, LLC, VIKING GLOBAL INVESTORS LP, BlackRock, Inc., VANGUARD GROUP INC, Long Focus Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MORGAN STANLEY, Sumitomo Mitsui Trust Group, Inc., and Nikko Asset Management Americas, Inc..
This page lists
160
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.